Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Tandem Diabetes Care's profit margin for the twelve months ending Jun 30, 2026 was -6.1%. For fiscal 2025 it was -20.2%, against -10.2% the year before. The highest annual figure on record is 2.2% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -20.2% | −10.0 |
| FY2024 | Dec 31, 2024 | -10.2% | +19.6 |
| FY2023 | Dec 31, 2023 | -29.8% | −18.0 |
| FY2022 | Dec 31, 2022 | -11.8% | −14.0 |
| FY2021 | Dec 31, 2021 | 2.2% | +9.1 |
| FY2020 | Dec 31, 2020 | -6.9% | −0.1 |
| FY2019 | Dec 31, 2019 | -6.8% | +59.9 |
| FY2018 | Dec 31, 2018 | -66.7% | +1.2 |
| FY2017 | Dec 31, 2017 | -67.9% | +31.2 |
| FY2016 | Dec 31, 2016 | -99.0% | +0.4 |
| FY2015 | Dec 31, 2015 | -99.4% | +60.5 |
| FY2014 | Dec 31, 2014 | -159.9% | +57.7 |
| FY2013 | Dec 31, 2013 | -217.7% | +1116.3 |
| FY2012 | Dec 31, 2012 | -1333.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -8.3% | +13.5 |
| Q1 FY2026 | Mar 31, 2026 | -8.2% | +47.4 |
| Q4 FY2025 | Dec 31, 2025 | -0.2% | −0.5 |
| Q3 FY2025 | Sep 30, 2025 | -8.5% | +1.0 |
| Q2 FY2025 | Jun 30, 2025 | -21.8% | −7.9 |
| Q1 FY2025 | Mar 31, 2025 | -55.7% | −33.4 |
| Q4 FY2024 | Dec 31, 2024 | 0.3% | +15.5 |
| Q3 FY2024 | Sep 30, 2024 | -9.5% | +8.2 |
| Q2 FY2024 | Jun 30, 2024 | -13.9% | +4.4 |
| Q1 FY2024 | Mar 31, 2024 | -22.3% | +50.8 |
| Q4 FY2023 | Dec 31, 2023 | -15.2% | −8.1 |
| Q3 FY2023 | Sep 30, 2023 | -17.8% | +6.2 |
| Q2 FY2023 | Jun 30, 2023 | -18.3% | −10.7 |
| Q1 FY2023 | Mar 31, 2023 | -73.1% | −64.8 |
| Q4 FY2022 | Dec 31, 2022 | -7.2% | −12.3 |
| Q3 FY2022 | Sep 30, 2022 | -23.9% | −27.2 |
| Q2 FY2022 | Jun 30, 2022 | -7.5% | −9.8 |
| Q1 FY2022 | Mar 31, 2022 | -8.4% | −4.8 |
| Q4 FY2021 | Dec 31, 2021 | 5.1% | −5.0 |
| Q3 FY2021 | Sep 30, 2021 | 3.2% | +10.8 |
| Q2 FY2021 | Jun 30, 2021 | 2.3% | +27.1 |
| Q1 FY2021 | Mar 31, 2021 | -3.6% | +11.6 |
| Q4 FY2020 | Dec 31, 2020 | 10.1% | +7.7 |
| Q3 FY2020 | Sep 30, 2020 | -7.6% | −4.5 |
| Q2 FY2020 | Jun 30, 2020 | -24.8% | −23.2 |
| Q1 FY2020 | Mar 31, 2020 | -15.2% | +19.7 |
| Q4 FY2019 | Dec 31, 2019 | 2.4% | −2.4 |
| Q3 FY2019 | Sep 30, 2019 | -3.1% | +71.0 |
| Q2 FY2019 | Jun 30, 2019 | -1.6% | +172.3 |
| Q1 FY2019 | Mar 31, 2019 | -34.8% | +85.0 |
| Q4 FY2018 | Dec 31, 2018 | 4.8% | +33.1 |
| Q3 FY2018 | Sep 30, 2018 | -74.0% | −14.6 |
| Q2 FY2018 | Jun 30, 2018 | -173.9% | −71.7 |
| Q1 FY2018 | Mar 31, 2018 | -119.9% | +5.5 |
| Q4 FY2017 | Dec 31, 2017 | -28.3% | +23.0 |
| Q3 FY2017 | Sep 30, 2017 | -59.4% | +183.2 |
| Q2 FY2017 | Jun 30, 2017 | -102.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -125.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -51.3% | – |
| Q3 FY2016 | Sep 30, 2016 | -242.5% | – |
See a number that looks wrong?